{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:07:46Z","timestamp":1777486066900,"version":"3.51.4"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Cherubism is a rare autosomal dominant disease characterized by expansile osteolytic jawbone lesions. The effect and safety of off-label calcitonin treatment during the progressive phase of the disease are not well described. In this retrospective study, we present data on the radiological response and adverse effects of subcutaneously administered calcitonin in a cohort of nine cherubism children (three female, six male). Two of the nine patients underwent two separate treatment courses with a significant off-treatment interval in between; therefore, a total of 11 treatment courses with a mean duration of 17.9\u2009months (range\u2009&amp;lt;1 to 35, SD 10.8) were studied. To measure the response, the cumulative volume of cherubism lesions was calculated from available three-dimensional imaging. The primary outcome was the change in the volume of lesions during calcitonin treatment and only assessed for the eight treatment courses with a minimal duration of 6\u2009months. A statistically significant reduction in the mean cumulative volume of lesions was seen regardless of treatment duration. Average volume reduction was highest in the first half year of treatment, with a gradual, ongoing reduction thereafter. For the secondary outcome, the change in the cumulative volume of lesions after treatment cessation was assessed for the seven treatment courses with follow-up imaging available. After six of these seven treatment courses, the cumulative volume increased again but remained undoubtedly smaller than the initial volume at the start of therapy. Adverse effects were assessed for all 11 treatment courses and occurred in 73% of them. Most adverse effects were mild and low grade, with the most severe being one grade 3 symptomatic hypocalcemia requiring hospitalization and early treatment termination. Calcitonin treatment seems effective and tolerable in treating actively progressing cherubism in children. However, further research is required to better understand the pharmacological treatment of cherubism, including also other drugs, dosing, and protocols. \u00a9 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).<\/jats:p>","DOI":"10.1002\/jbmr.4922","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T13:36:37Z","timestamp":1697117797000},"page":"1822-1833","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and Toxicity of Calcitonin Treatment in Children with Cherubism: A Single-Center Cohort Study"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0944-4356","authenticated-orcid":false,"given":"Willem H.","family":"Schreuder","sequence":"first","affiliation":[{"name":"Department of Head and Neck Surgery and Oncology Antoni van Leeuwenhoek, Netherlands Cancer Center Amsterdam the Netherlands"},{"name":"Department of Oral and Maxillofacial Surgery, Amsterdam University Medical Centers Location AMC and Academic Center for Dentistry Amsterdam University of Amsterdam Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan B.","family":"Meijer","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Amsterdam University Medical Centers Location AMC and Academic Center for Dentistry Amsterdam University of Amsterdam Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3672-4348","authenticated-orcid":false,"given":"Arjen H.G.","family":"Cleven","sequence":"additional","affiliation":[{"name":"Department of Pathology University Medical Center Groningen Groningen the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Edelenbos","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Amsterdam University Medical Centers Location AMC University of Amsterdam Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis","family":"Klop","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Amsterdam University Medical Centers Location AMC and Academic Center for Dentistry Amsterdam University of Amsterdam Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2429-2071","authenticated-orcid":false,"given":"Ruud","family":"Schreurs","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Amsterdam University Medical Centers Location AMC and Academic Center for Dentistry Amsterdam University of Amsterdam Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-3938","authenticated-orcid":false,"given":"Renate T.","family":"de Jong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine section Amsterdam UMC location Vrije Universiteit Amsterdam Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merel C.","family":"van Maarle","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Amsterdam UMC University of Amsterdam Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy B.G.","family":"Horsthuis","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Ziekenhuisgroep Twente Almelo and Medisch Spectrum Twente Enschede the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0096-8217","authenticated-orcid":false,"given":"Jan","family":"de Lange","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Amsterdam University Medical Centers Location AMC and Academic Center for Dentistry Amsterdam University of Amsterdam Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Amsterdam University Medical Centers Location AMC University of Amsterdam Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"2024022211064325500_jbmr4922-bib-0001","doi-asserted-by":"crossref","first-page":"115935","DOI":"10.1016\/j.bone.2021.115935","article-title":"Multiple versus solitary Giant cell lesions of the jaw: similar or distinct entities?","volume":"149","author":"Schreuder","year":"2021","journal-title":"Bone"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0002","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1750-1172-7-S1-S6","article-title":"Cherubism: best clinical practice","volume":"7","author":"Papadaki","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0003","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijom.2020.05.021","article-title":"Cherubism: a systematic literature review of clinical and molecular aspects","volume":"50","author":"Chrcanovic","year":"2021","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0004","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/302456","article-title":"The gene for cherubism maps to chromosome 4p16","volume":"65","author":"Tiziani","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1086\/302454","article-title":"The gene for cherubism maps to chromosome 4p16.3","volume":"65","author":"Mangion","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2024022211064325500_jbmr4922-bib-0006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/88832","article-title":"Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism","volume":"28","author":"Ueki","year":"2001","journal-title":"Nat Genet"},{"key":"2024022211064325500_jbmr4922-bib-0007","volume-title":"WHO Classification of Head and Neck Tumours","author":"El-Naggar","year":"2017","edition":"4th ed"},{"issue":"8","key":"2024022211064325500_jbmr4922-bib-0008","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1054\/bjps.2001.3701","article-title":"Cherubism and its charlatans","volume":"54","author":"Lannon","year":"2001","journal-title":"Br J Plast Surg"},{"issue":"6","key":"2024022211064325500_jbmr4922-bib-0009","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.celrep.2014.08.023","article-title":"Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism","volume":"8","author":"Yoshitaka","year":"2014","journal-title":"Cell Rep"},{"issue":"6","key":"2024022211064325500_jbmr4922-bib-0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1034\/j.1600-0714.2003.00126.x","article-title":"Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts","volume":"32","author":"Liu","year":"2003","journal-title":"J Oral Pathol Med."},{"issue":"4","key":"2024022211064325500_jbmr4922-bib-0011","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1034\/j.1600-0714.2003.00069.x","article-title":"Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw","volume":"32","author":"Itonaga","year":"2003","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"2024022211064325500_jbmr4922-bib-0012","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.tripleo.2007.04.003","article-title":"Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options","volume":"104","author":"de Lange","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"2024022211064325500_jbmr4922-bib-0013","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0266-4356(93)90168-V","article-title":"Central giant cell granulomas of the jaws regress with calcitonin therapy","volume":"31","author":"Harris","year":"1993","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"8","key":"2024022211064325500_jbmr4922-bib-0014","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.joms.2006.06.266","article-title":"Cherubism treated with calcitonin: report of a case","volume":"65","author":"de Lange","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"2024022211064325500_jbmr4922-bib-0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0039-1698923","article-title":"Treatment of cherubism with salmon calcitonin: a case report","volume":"5","author":"Etoz","year":"2011","journal-title":"European J Dentistry"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0016","first-page":"34","article-title":"Man with cherubism","volume":"144","author":"Hart","year":"2000","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"2","key":"2024022211064325500_jbmr4922-bib-0017","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12105-013-0489-1","article-title":"Cherubism","volume":"8","author":"Komerik","year":"2014","journal-title":"Head Neck Pathol"},{"key":"2024022211064325500_jbmr4922-bib-0018","first-page":"340960","article-title":"Clinical and surgical management of an aggressive cherubism treated with autogenous bone graft and calcitonin","volume":"2011","author":"Fernandes Gomes","year":"2011","journal-title":"ISRN Dent."},{"issue":"2","key":"2024022211064325500_jbmr4922-bib-0019","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/ams.ams_177_17","article-title":"Cherubism in 12 year young female","volume":"8","author":"Mazhar","year":"2018","journal-title":"Ann Maxillofac Surg"},{"issue":"11","key":"2024022211064325500_jbmr4922-bib-0020","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0278-2391(98)90618-8","article-title":"Treatment of cherubism with locally aggressive behavior presenting in adulthood: report of four cases and a proposed new grading system","volume":"56","author":"Kalantar Motamedi","year":"1998","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"2024022211064325500_jbmr4922-bib-0021","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/01.sap.0000248141.36904.19","article-title":"Two-stage surgical treatment of severe cherubism","volume":"58","author":"Raposo-Amaral","year":"2007","journal-title":"Ann Plast Surg"},{"issue":"2","key":"2024022211064325500_jbmr4922-bib-0022","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jcms.2016.11.011","article-title":"Pharmacological and surgical therapy for the central giant cell granuloma: a long-term retrospective cohort study","volume":"45","author":"Schreuder","year":"2017","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0023","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF00349920","article-title":"The computed tomographic appearances of cherubism","volume":"16","author":"Bianchi","year":"1987","journal-title":"Skeletal Radiol"},{"issue":"10","key":"2024022211064325500_jbmr4922-bib-0024","doi-asserted-by":"crossref","first-page":"20130034","DOI":"10.1259\/dmfr.20130034","article-title":"Cherubism: panoramic and CT features in adults","volume":"42","author":"Redfors","year":"2013","journal-title":"Dentomaxillofac Radiol"},{"issue":"4","key":"2024022211064325500_jbmr4922-bib-0025","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2214\/ajr.182.4.1821051","article-title":"Imaging characteristics of cherubism","volume":"182","author":"Beaman","year":"2004","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"2024022211064325500_jbmr4922-bib-0026","first-page":"e2","article-title":"Cherubism: clinicoradiographic features and treatment","volume":"1","author":"Lima Gde","year":"2010","journal-title":"J Oral Maxillofac Res"},{"issue":"4","key":"2024022211064325500_jbmr4922-bib-0027","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13244-018-0623-4","article-title":"Masses of developmental and genetic origin affecting the paediatric craniofacial skeleton","volume":"9","author":"Stefanelli","year":"2018","journal-title":"Insights Imaging"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0028","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1590\/0103-6440201301861","article-title":"Clinical and imagiological findings of central giant cell lesion and cherubism","volume":"24","author":"Pinheiro","year":"2013","journal-title":"Braz Dent J"},{"issue":"5","key":"2024022211064325500_jbmr4922-bib-0029","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1148\/rg.2015140267","article-title":"CT dose optimization in pediatric radiology: a multiyear effort to preserve the benefits of imaging while reducing the risks","volume":"35","author":"Greenwood","year":"2015","journal-title":"Radiographics"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF03350260","article-title":"Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study","volume":"14","author":"Pontiroli","year":"1991","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0031","first-page":"9","article-title":"Comparison of calcitonin tolerance after intramuscular or intranasal administration in treatment for postmenopausal osteoporosis","volume":"53","author":"Horst-Sikorska","year":"1996","journal-title":"Przegl Lek"},{"key":"2024022211064325500_jbmr4922-bib-0032","author":"European-Medicines-Agency","year":"2013"},{"issue":"11","key":"2024022211064325500_jbmr4922-bib-0033","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1172\/JCI35711","article-title":"NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism","volume":"118","author":"Aliprantis","year":"2008","journal-title":"J Clin Invest"},{"issue":"3","key":"2024022211064325500_jbmr4922-bib-0034","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3892\/ol.2011.274","article-title":"Increased expression of NFATc1 in giant cell lesions of the jaws, cherubism and brown tumor of hyperparathyroidism","volume":"2","author":"Duarte","year":"2011","journal-title":"Oncol Lett"},{"issue":"4","key":"2024022211064325500_jbmr4922-bib-0035","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bbrc.2008.04.080","article-title":"SH3BP2 is an activator of NFAT activity and osteoclastogenesis","volume":"371","author":"Lietman","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2024022211064325500_jbmr4922-bib-0036","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-0714.2009.00855.x","article-title":"NFATc1 and TNFalpha expression in giant cell lesions of the jaws","volume":"39","author":"Amaral","year":"2010","journal-title":"J Oral Path Med"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0037","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cell.2006.10.047","article-title":"Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 \"cherubism\" mice","volume":"128","author":"Ueki","year":"2007","journal-title":"Cell"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0038","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2006.12.019","article-title":"Jawing about TNF: new hope for cherubism","volume":"128","author":"Novack","year":"2007","journal-title":"Cell"},{"issue":"12","key":"2024022211064325500_jbmr4922-bib-0039","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/jbmr.2295","article-title":"SH3BP2 cherubism mutation potentiates TNF-alpha-induced osteoclastogenesis via NFATc1 and TNF-alpha-mediated inflammatory bone loss","volume":"29","author":"Mukai","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0040","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1750-1172-7-S1-S5","article-title":"The role of SH3BP2 in the pathophysiology of cherubism","volume":"7","author":"Reichenberger","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0041","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bone.2012.10.003","article-title":"Anti-tumor necrosis factor treatment in cherubism\u2014clinical, radiological and histological findings in two children","volume":"52","author":"Hero","year":"2013","journal-title":"Bone"},{"issue":"1","key":"2024022211064325500_jbmr4922-bib-0042","first-page":"147","article-title":"Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism","volume":"29","author":"Pagnini","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"2024022211064325500_jbmr4922-bib-0043","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jbmr.2431","article-title":"The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism","volume":"30","author":"Kadlub","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024022211064325500_jbmr4922-bib-0044","first-page":"75","article-title":"Cherubism in 8-years old child: treatment experience","volume":"1","author":"Kugushev","year":"2018","journal-title":"MOJ Tumor Res"},{"issue":"12","key":"2024022211064325500_jbmr4922-bib-0045","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.joms.2020.06.016","article-title":"Positive outcomes of denosumab treatment in 2 patients with cherubism","volume":"78","author":"Bar Droma","year":"2020","journal-title":"J Oral Maxillofac Surg"},{"issue":"12","key":"2024022211064325500_jbmr4922-bib-0046","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1177\/10556656221113891","article-title":"Denosumab therapy in cherubism","volume":"60","author":"Liles","year":"2023","journal-title":"Cleft Palate Craniofac J"},{"issue":"10","key":"2024022211064325500_jbmr4922-bib-0047","doi-asserted-by":"crossref","first-page":"e10210","DOI":"10.1002\/jbm4.10210","article-title":"Use of denosumab in children with osteoclast bone Dysplasias: report of three cases","volume":"3","author":"Upfill-Brown","year":"2019","journal-title":"JBMR Plus"},{"issue":"3","key":"2024022211064325500_jbmr4922-bib-0048","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.joms.2020.10.001","article-title":"Adjuvant Alendronic acid in the Management of Severe Cherubism: a case report and literature review","volume":"79","author":"Bradley","year":"2021","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"2024022211064325500_jbmr4922-bib-0049","doi-asserted-by":"crossref","first-page":"1278.e1","DOI":"10.1016\/j.joms.2019.02.021","article-title":"A paradigm shift in the Management of Cherubism? A preliminary report using imatinib","volume":"77","author":"Ricalde","year":"2019","journal-title":"J Oral Maxillofac Surg"},{"issue":"7","key":"2024022211064325500_jbmr4922-bib-0050","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1055\/s-0043-105074","article-title":"Involution von cherubismus im MRT unter therapie mit imatinib","volume":"189","author":"Eiden","year":"2017","journal-title":"Rofo"},{"issue":"11","key":"2024022211064325500_jbmr4922-bib-0051","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2014-3072","article-title":"Effect of denosumab on the growing skeleton in osteogenesis imperfecta","volume":"99","author":"Hoyer-Kuhn","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024022211064325500_jbmr4922-bib-0052","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00247-020-04651-y","article-title":"Dense sclerotic metaphyseal bands caused by denosumab therapy","volume":"50","author":"Dunnion","year":"2020","journal-title":"Pediatr Radiol"},{"issue":"7","key":"2024022211064325500_jbmr4922-bib-0053","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024022211064325500_jbmr4922-bib-0054","doi-asserted-by":"crossref","first-page":"470","DOI":"10.21037\/tp-22-276","article-title":"Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review","volume":"12","author":"Wang","year":"2023","journal-title":"Transl Pediatr"},{"issue":"2","key":"2024022211064325500_jbmr4922-bib-0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11420-009-9115-x","article-title":"Is there a role for NFAT inhibitors in the prevention of bone destruction?","volume":"5","author":"McMahon","year":"2009","journal-title":"HSS J"},{"issue":"5","key":"2024022211064325500_jbmr4922-bib-0056","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000365889","article-title":"The use of bisphosphonates in pediatrics","volume":"82","author":"Baroncelli","year":"2014","journal-title":"Horm Res Paediatr"},{"issue":"7","key":"2024022211064325500_jbmr4922-bib-0057","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1515\/jpem-2019-0581","article-title":"Efficacy and safety of denosumab treatment in a prepubertal patient with cherubism","volume":"33","author":"Kawamura","year":"2020","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/38\/12\/1822\/56738760\/jbmr4922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/38\/12\/1822\/56738760\/jbmr4922.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:47:55Z","timestamp":1710341275000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/38\/12\/1822-1833\/7610372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,1]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4922","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,1]]},"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"2023-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}